Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
AADI similar filings
- 1 Nov 21 Aadi Bioscience Appoints Scott Giacobello as Chief Financial Officer
- 24 Sep 21 Index to Financial Statements
- 20 Sep 21 Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
- 13 Sep 21 Aadi Bioscience Appoints Emma Reeve to its Board of Directors
- 3 Sep 21 Entry into a Material Definitive Agreement
- 26 Aug 21 Entry into a Material Definitive Agreement
- 23 Aug 21 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 16.1
September 9, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated September 9, 2021, of Aadi Bioscience, Inc. and are in agreement with the statements contained in the third paragraph on page one therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP